Phibro Animal Health (PAHC) EBT (QoQ) (2012 - 2026)
Phibro Animal Health (PAHC) EBT (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.29% |
| Dec 31, 2025 | 0.44% |
| Sep 30, 2025 | 52.08% |
| Jun 30, 2025 | -19.67% |
| Mar 31, 2025 | 513.64% |
| Dec 31, 2024 | -49.71% |
| Sep 30, 2024 | 135.20% |
| Jun 30, 2024 | -311.48% |
| Mar 31, 2024 | 262.47% |
| Dec 31, 2023 | 129.76% |
| Sep 30, 2023 | -155.87% |
| Jun 30, 2023 | 41.96% |
| Mar 31, 2023 | 24.73% |
| Dec 31, 2022 | 123.54% |
| Sep 30, 2022 | -56.21% |
| Jun 30, 2022 | -53.90% |
| Mar 31, 2022 | 14.04% |
| Dec 31, 2021 | 145.23% |
| Sep 30, 2021 | -40.50% |
| Jun 30, 2021 | -9.32% |